Yehia Mokhtar Farag
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yehia Mokhtar Farag has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Frode S. Berven
Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Bergen, Norway
2 shared publications - Marc Vaudel
Mohn Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway
2 shared publications - Astrid Guldbrandsen
Knowledge Centre for Education, University of Stavanger, 4021 Stavanger, Norway
1 shared publication Carlos Horro
Proteomics Unit, Department of Biomedicine, University of Bergen, 5020 Bergen, Norway
1 shared publication- Elise Aasebø
Acute Leukemia Research Group, Department of Clinical Science, University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway
1 shared publication - Frode Selheim
Proteomics Unit of University of Bergen (PROBE), University of Bergen, Jonas Lies vei 91, 5009 Bergen, Norway
1 shared publication
Latest Publications
- Open Access
- 28 October 2021
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 20 (12) , 5419-5423
PeptideShaker Online: A User-Friendly Web-Based Framework for the Identification of Mass Spectrometry-Based Proteomics Data
- 28 October 2021
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 20 (12) , 5419-5423
Open AccessPeptideShaker Online: A User-Friendly Web-Based Framework for the Identification of Mass Spectrometry-Based Proteomics Data
- 21 August 2019
- Published by Springer Nature
- Vol. 2044, 377-391
Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR)
Every year, a large number of published studies present biomarkers for various neurological disorders. Many of these studies are based on mass spectrometry proteomics data and describe comparison of the abundance of proteins in cerebrospinal fluid between two or more disease groups. As the number of such studies is growing, it is no longer straightforward to obtain an overview of which specific proteins are increased or decreased between the numerous relevant diseases and their many subcategories, or to see the larger picture or trends between related diseases. To alleviate this situation, we therefore mined the literature for mass spectrometry–based proteomics studies including quantitative protein data from cerebrospinal fluid of patients with multiple sclerosis, Alzheimer’s disease, and Parkinson’s disease and organized the extracted data in the Cerebrospinal Fluid Proteome Resource (CSF-PR). CSF-PR is freely available online at http://probe.uib.no/csf-pr , is highly interactive, and allows for easy navigation, visualization, and export of the published scientific data. This chapter will guide the user through some of the most important features of the tool and show examples of the suggested use cases.
- 21 August 2019
- Published by Springer Nature
- Vol. 2044, 377-391
Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR)
Every year, a large number of published studies present biomarkers for various neurological disorders. Many of these studies are based on mass spectrometry proteomics data and describe comparison of the abundance of proteins in cerebrospinal fluid between two or more disease groups. As the number of such studies is growing, it is no longer straightforward to obtain an overview of which specific proteins are increased or decreased between the numerous relevant diseases and their many subcategories, or to see the larger picture or trends between related diseases. To alleviate this situation, we therefore mined the literature for mass spectrometry–based proteomics studies including quantitative protein data from cerebrospinal fluid of patients with multiple sclerosis, Alzheimer’s disease, and Parkinson’s disease and organized the extracted data in the Cerebrospinal Fluid Proteome Resource (CSF-PR). CSF-PR is freely available online at http://probe.uib.no/csf-pr , is highly interactive, and allows for easy navigation, visualization, and export of the published scientific data. This chapter will guide the user through some of the most important features of the tool and show examples of the suggested use cases.
- 1 August 2016
- Published by Elsevier in Journal of Proteomics
- Vol. 145, 214-225
Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows
- 1 August 2016
- Published by Elsevier in Journal of Proteomics
- Vol. 145, 214-225
Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows